Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia 53Leukemia, Myeloid, Acute 33Leukemia, Lymphocytic, Chronic, B-Cell 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Lymphoma 27Lymphoma, Non-Hodgkin 22Myelodysplastic Syndromes 21Lymphoma, Follicular 21Lymphoma, Mantle-Cell 20Lymphoma, Large B-Cell, Diffuse 20Leukemia, Myeloid, Chronic-Phase 19Lymphoma, Large-Cell, Immunoblastic 18Burkitt Lymphoma 18Lymphoma, B-Cell, Marginal Zone 17Hodgkin Disease 17Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15Congenital Abnormalities 15Multiple Myeloma 14Leukemia, Myeloid, Accelerated Phase 14Neoplasms, Plasma Cell 10Blast Crisis 10Myeloproliferative Disorders 9Leukemia, Monocytic, Acute 9Leukemia, Megakaryoblastic, Acute 9Leukemia, Erythroblastic, Acute 9Leukemia, Myelomonocytic, Chronic 8Leukemia, Myelomonocytic, Acute 8Anemia, Refractory, with Excess of Blasts 8Waldenstrom Macroglobulinemia 7Recurrence 7

Interventions

fludarabine phosphate 22Cyclophosphamide 22Peripheral Blood Stem Cell Transplantation 21Tacrolimus 15Busulfan 14Cyclosporine 13Whole-Body Irradiation 12Mycophenolic Acid 12Methotrexate 12Antilymphocyte Serum 10Filgrastim 7Etoposide 6Radiotherapy 5Methylprednisolone 5Decitabine 5Carboplatin 5ruxolitinib 4fludarabine 4Melphalan 4Flow Cytometry 4Topotecan 3Thiotepa 3Cytogenetic Analysis 3Cytarabine 3veliparib 2merphos 2liposomal amphotericin B 2aldesleukin 2Watchful Waiting 2Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thrombocythemia, Essential × sargramostim × Other hematologic neoplasm × Clear all
NCT00004036 2013-12-19

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

National Cancer Institute (NCI)

Phase 1 Unknown
30 enrolled
LymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Precancerous Conditions, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Primary Myelofibrosis, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡